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Editors’ NotesHeterogeneity in Pluripotent Stem Cells
Recent evidence of genetic and epigenetic heterogeneity in pluripotent stem cells
has raised concerns about both generality of conclusions and potential applica-
tions. In this issue, several groups tackle this subject. Eggan and colleagues
examine the use of hiPSCs for modeling an X-linked disease, Lesch-Nyhan
Syndrome. While they observe an X-linked neuronal disease phenotype in male
cells, they witness erosion of X chromosome inactivation (XCI) in late-passage
hiPSCs from females that masks the disease phenotype. Laurent and colleagues
also examined epigenetic variation in hPSCs and found heterogeneity in terms of
DNAmethylation, reflected by aberrant imprinting and XCI. As in the Eggan group’s
study, these alterations were also retained in differentiated cells, providing
a cautionary warning for choosing cell sources in X-linked disease modeling. In
a similar vein, Ley and colleagues investigated the source of genetic variation
seen in iPSCs and found that it arises fromclonal capture of variant cells in the start-
ing population rather than from the reprogramming process per se, arguing against
the idea that reprogramming is inherentlymutagenic but nevertheless raising ques-
tions about sequence variation between iPSC lines. Hendrich and colleaguesfocused on a different aspect of heterogeneity by looking at transcriptional regulation mediated by the NuRD complex.
They implicateNuRD indynamic regulationofpluripotencygenes (KLF4staining shownabove), andsuggest that this transcrip-
tional heterogeneity is key to maintaining differentiation responsiveness of pluripotent cells. In their minireview, Hu andWade
discuss this newly uncovered role for NuRD in the context of the Hendrich group’s study and several other recent reports.Muscle Regeneration
The regenerative capacity of skeletal muscle has been known for well over
a century, but the cellular basis for this ability was not known until 50 years
ago when Mauro first identified the satellite cell. To commemorate this mile-
stone, Brack and Rando discuss the current state of the satellite cell field
through the lens of stem cell biology. Currently, there are twomajor approaches
to enhancing muscle stem cell function in cases of injury or neuromuscular
disease—enhancing engraftment ability in transplantation and mobilizing
endogenous stem cells for repair. Perlingeiro and colleagues focus on the
problemof generating sufficient amounts of stem/progenitor cells for transplan-
tation. Through conditional expression of Pax7 in hPSCs, these authors
generate engraftable skeletal muscle precursors that are able to seed the satel-
lite cell compartment and restore function in dystrophic muscle. In contrast,
Wagers and colleagues took a different approach to enhancingmuscle stemcell function through the use of caloric restriction.
In this study, Cerletti et al. observe improved muscle stem cell function in terms of both endogenous muscle repair and
engraftment in transplant recipients. Stem-cell-based interventions aimed at restoring normal function are becoming an
increasing reality, and a growing biomedical industry is quickly filling this niche. To keep our readers updated on such
endeavors, in this issue we have introduced a new quarterly feature called ‘‘Industry Progress.’’ In these articles, Brindley
and colleagues provide an overview of clinical, commercial, and financial progress made by public companies operating
in the cell-based therapy arena.Hormone Signaling and
Stem Cells
The key role of the stem cell niche in controlling cell
fate decisions and stem cell behavior is well known,
and how hormone signals can be integrated in
tissue-specific contexts to influence niche homeo-
stasis is emerging as an important component of
niche regulation. In this issue, Tang and colleagues
identify a subpopulation of prostate cancer cells
expressing low levels of the androgen-regulated
differentiation marker PSA that function as cancer
stem cells. These cells are refractory to androgendeprivation therapies, and MaxWicha discusses the implications of these findings for therapeutic approaches in his preview.
In another example of hormone regulation of stem cells, Demeneix and colleagues identify a role for thyroid hormone in medi-
ating adult neural stem cell commitment in the subventricular zone of the adult brain, which occurs through repression of Sox2
by the thyroid hormone receptor TRa1.Cell Stem Cell 10, May 4, 2012 ª2012 Elsevier Inc. xv
